Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatme... BusinessWire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on MRK
    Thinking about buying stock in Diamondback Energy, Merck, High Tide, Rumble, or SNDL?
    9:31a ET March 27 '24 PR Newswire

    InvestorsObserver issues critical PriceWatch Alerts for FANG, MRK, HITI, RUM, and SNDL.

    https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

    To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

    -- FANG: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=FANG&prnumber=202403272

    -- MRK: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MRK&prnumber=202403272

    -- HITI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=HITI&prnumber=202403272

    -- RUM: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RUM&prnumber=202403272

    -- SNDL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SNDL&prnumber=202403272

    (Note: You may have to copy this link into your browser then press the [ENTER] key.)

    InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

    InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

    https://c212.net/c/img/favicon.png?sn=CG72375&sd=2024-03-27

    View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-diamondback-energy-merck-high-tide-rumble-or-sndl-302101067.html

    SOURCE InvestorsObserver

    https://rt.newswire.ca/rt.gif?NewsItemId=CG72375&Transmission_Id=202403270931PR_NEWS_USPR_____CG72375&DateId=20240327

    COMTEX_449913132/1005/2024-03-27T09:31:26

    Merck Provides Update on Phase 3 KeyVibe-010 Trial Evaluating an Inve...
    6:45a ET May 13 '24 BusinessWire
    Health Canada Approves KEYTRUDA® for adult patients with locally adv...
    7:05a ET May 9 '24 CNW Group
    Health Canada Approves KEYTRUDA(R) for adult patients with locally ad...
    7:05a ET May 9 '24 PR Newswire
    Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUD...
    6:45a ET May 9 '24 BusinessWire
    Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Ma...
    8:30a ET May 8 '24 GlobeNewswire
    Merck to Participate in the Bank of America Securities 2024 Healthcar...
    6:45a ET May 8 '24 BusinessWire
    Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint o...
    7:15a ET May 1 '24 BusinessWire
    Merck Announces Positive Data for V116, an Investigational, 21-Valent...
    9:00a ET April 29 '24 BusinessWire
    Merck Announces First-Quarter 2024 Financial Results
    6:30a ET April 25 '24 BusinessWire
    Health Canada Approves KEYTRUDA(R) as a first-line treatment for adul...
    7:04a ET April 19 '24 PR Newswire

    Market data provided by News provided by